Right to FDA-Approved Medicines Act

House Bill

H.R. 4525

119th Congress

Right to FDA-Approved Medicines Act

In Committee

Introduced:Aug 12, 2025

Primary Sponsor

Eleanor Holmes Norton

Representative

Democratic

DC

Cosponsors

5

Quick Stats

Policy Area

Health

Summary

This bill would require certain retailers, such as stores and restaurants, to allow customers with eligible medical conditions like inflammatory bowel disease to use non-public restrooms if they need immediate access to a restroom.

Latest Action

Referred to the Subcommittee on Health.

SponsorEleanor Holmes Norton (D-DC)

Introduced8/12/2025

StatusReferred to the House Committee on Energy and Commerce.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Right to FDA-Approved Medicines Act

This bill would require certain retailers, such as stores and restaurants, to allow customers with eligible medical conditions like inflammatory bowel disease to use non-public restrooms if they need immediate access to a restroom.

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would require certain retailers, such as stores and restaurants, to allow customers with eligible medical conditions like inflammatory bowel disease to use non-public restrooms if they need immediate access to a restroom.

Bill Number: 4525
Sponsor: Eleanor Holmes Norton (D-DC)
Introduced: 8/12/2025
Status: Referred to the House Committee on Energy and Commerce.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Right to FDA-Approved Medicines Act
Bill Number: 4525
Sponsor: Eleanor Holmes Norton (D-DC)
Status: Referred to the House Committee on Energy and Commerce.
Introduced: 8/12/2025
Summary: This bill would require certain retailers, such as stores and restaurants, to allow customers with eligible medical conditions like inflammatory bowel disease to use non-public restrooms if they need immediate access to a restroom.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill would require certain retailers, such as stores and restaurants, to allow customers with eligible medical conditions like inflammatory bowel disease to use non-public restrooms if they need immediate access to a restroom.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Restroom Access Act of 2023 This bill requires retailers to allow a customer to use a nonpublic restroom if the customer has an eligible medical condition (e.g., inflammatory bowel disease) that requires immediate access to a restroom and other conditions are met.

Key Points

Main provisions of the bill

Retailers must allow customers with eligible medical conditions to use non-public restrooms if they need immediate access.
Eligible conditions include inflammatory bowel disease and other conditions that require urgent restroom access.
Retailers must post a sign informing customers of this right.

How This Impacts Americans

Potential effects on citizens and communities

This bill would positively impact people with certain medical conditions that require urgent restroom access, by ensuring they can use non-public restrooms at participating retailers. This could improve quality of life and prevent embarrassing or uncomfortable situations for those affected.

Policy Areas

Primary Policy Area

Health

Related Subjects

Health information and medical records

Retail and wholesale trades

Service industries

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

4525, 119th Congress (2025). "Right to FDA-Approved Medicines Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-4525

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.